233 related articles for article (PubMed ID: 33462744)
1. Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas.
Nakhleh A; Assaliya Naffa M; Sviri G; Shehadeh N; Hochberg I
Pituitary; 2021 Aug; 24(4):492-498. PubMed ID: 33462744
[TBL] [Abstract][Full Text] [Related]
2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
3. What is the natural history of nonoperated nonfunctioning pituitary adenomas?
Karavitaki N; Collison K; Halliday J; Byrne JV; Price P; Cudlip S; Wass JA
Clin Endocrinol (Oxf); 2007 Dec; 67(6):938-43. PubMed ID: 17692109
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas.
Lenders N; Ikeuchi S; Russell AW; Ho KK; Prins JB; Inder WJ
Clin Endocrinol (Oxf); 2016 Feb; 84(2):222-228. PubMed ID: 26291181
[TBL] [Abstract][Full Text] [Related]
5. Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months.
Elsässer Imboden PN; De Tribolet N; Lobrinus A; Gaillard RC; Portmann L; Pralong F; Gomez F
Medicine (Baltimore); 2005 May; 84(3):188-196. PubMed ID: 15879908
[TBL] [Abstract][Full Text] [Related]
6. Pituitary tumor apoplexy in patients with Cushing's disease: endocrinologic and visual outcomes after transsphenoidal surgery.
Choudhry OJ; Choudhry AJ; Nunez EA; Eloy JA; Couldwell WT; Ciric IS; Liu JK
Pituitary; 2012 Sep; 15(3):428-35. PubMed ID: 21927887
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in patients with nonfunctioning pituitary adenomas managed conservatively.
Sam AH; Shah S; Saleh K; Joshi J; Roncaroli F; Robinson S; Cox J; Martin NM; Mendoza N; Meeran K; Mehta A; Dhillo WS
Clin Endocrinol (Oxf); 2015 Dec; 83(6):861-5. PubMed ID: 26201671
[TBL] [Abstract][Full Text] [Related]
8. Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience.
Marić A; Kruljac I; Čerina V; Pećina HI; Šulentić P; Vrkljan M
Croat Med J; 2012 Jun; 53(3):224-33. PubMed ID: 22661135
[TBL] [Abstract][Full Text] [Related]
9. Clinically Nonfunctioning Pituitary Incidentalomas: Characteristics and Natural History.
Tresoldi AS; Carosi G; Betella N; Del Sindaco G; Indirli R; Ferrante E; Sala E; Giavoli C; Morenghi E; Locatelli M; Milani D; Mazziotti G; Spada A; Arosio M; Mantovani G; Lania AGA
Neuroendocrinology; 2020; 110(7-8):595-603. PubMed ID: 31525736
[TBL] [Abstract][Full Text] [Related]
10. Apoplexy in pituitary microadenomas.
Randall BR; Couldwell WT
Acta Neurochir (Wien); 2010 Oct; 152(10):1737-40. PubMed ID: 20549261
[TBL] [Abstract][Full Text] [Related]
11. Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes.
Hwang YC; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
J Korean Med Sci; 2009 Feb; 24(1):46-51. PubMed ID: 19270812
[TBL] [Abstract][Full Text] [Related]
12. Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas.
Selvais P; Donckier J; Buysschaert M; Maiter D
Eur J Endocrinol; 1998 Feb; 138(2):153-9. PubMed ID: 9506858
[TBL] [Abstract][Full Text] [Related]
13. Differences in clinical, hormonal, and radiological presentation and in surgical outcomes in patients presenting with and without pituitary apoplexy. A multicenter study of 245 cases.
Araujo-Castro M; Paredes I; Pérez-López C; García Feijoo P; Alvarez-Escola C; Calatayud M; Lagares A; Soledad Librizzi M; Acitores Cancela A; Rodríguez Berrocal V
Pituitary; 2023 Apr; 26(2):250-258. PubMed ID: 37103720
[TBL] [Abstract][Full Text] [Related]
14. Time Course of Symptomatic Recovery After Endoscopic Transsphenoidal Surgery for Pituitary Adenoma Apoplexy in the Modern Era.
Zaidi HA; Cote DJ; Burke WT; Castlen JP; Bi WL; Laws ER; Dunn IF
World Neurosurg; 2016 Dec; 96():434-439. PubMed ID: 27663263
[TBL] [Abstract][Full Text] [Related]
15. Developing an optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas.
Kim JH; Dho YS; Kim YH; Lee JH; Lee JH; Hong AR; Shin CS
J Neurosurg; 2018 Sep; 131(2):500-506. PubMed ID: 30215565
[TBL] [Abstract][Full Text] [Related]
16. Pituitary apoplexy: An emergent and potential life-threatening complication of pituitary adenomas.
Geyik AM; Durmaz MO; Dogan A; Kaya Uğur B; Geyik S; Erkutlu İ; Yasar S; Kırık A; Kose G; Nehir A
Ulus Travma Acil Cerrahi Derg; 2022 Apr; 28(4):483-489. PubMed ID: 35485523
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenomas in childhood and adolescence.
Kane LA; Leinung MC; Scheithauer BW; Bergstralh EJ; Laws ER; Groover RV; Kovacs K; Horvath E; Zimmerman D
J Clin Endocrinol Metab; 1994 Oct; 79(4):1135-40. PubMed ID: 7525627
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly complicated with fulminant pituitary apoplexy: clinical characteristic analysis and review of literature.
Zheng XQ; Zhou X; Yao Y; Deng K; You H; Duan L; Zhu HJ
Endocrine; 2023 Jul; 81(1):160-167. PubMed ID: 37195580
[TBL] [Abstract][Full Text] [Related]
19. Management and outcomes of pituitary apoplexy.
Singh TD; Valizadeh N; Meyer FB; Atkinson JL; Erickson D; Rabinstein AA
J Neurosurg; 2015 Jun; 122(6):1450-7. PubMed ID: 25859804
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
